These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15172737)

  • 1. Evidence supporting a role for anti-Abeta antibodies in the treatment of Alzheimer's disease.
    Morgan D; Gitter BD
    Neurobiol Aging; 2004; 25(5):605-8. PubMed ID: 15172737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy of Alzheimer's disease (AD): from murine models to anti-amyloid beta (Abeta) human monoclonal antibodies.
    Geylis V; Steinitz M
    Autoimmun Rev; 2006 Jan; 5(1):33-9. PubMed ID: 16338209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulin and Alzheimer's disease immunotherapy.
    Solomon B
    Curr Opin Mol Ther; 2007 Feb; 9(1):79-85. PubMed ID: 17330405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel approaches for immunotherapeutic intervention in Alzheimer's disease.
    Vasilevko V; Cribbs DH
    Neurochem Int; 2006 Jul; 49(2):113-26. PubMed ID: 16765487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain.
    Boche D; Zotova E; Weller RO; Love S; Neal JW; Pickering RM; Wilkinson D; Holmes C; Nicoll JA
    Brain; 2008 Dec; 131(Pt 12):3299-310. PubMed ID: 18953056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy as treatment for Alzheimer's disease.
    Hawkes CA; McLaurin J
    Expert Rev Neurother; 2007 Nov; 7(11):1535-48. PubMed ID: 17997702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy against APP beta-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain abeta levels.
    Rakover I; Arbel M; Solomon B
    Neurodegener Dis; 2007; 4(5):392-402. PubMed ID: 17536186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lifelong immunization with human beta-amyloid (1-42) protects Alzheimer's transgenic mice against cognitive impairment throughout aging.
    Jensen MT; Mottin MD; Cracchiolo JR; Leighty RE; Arendash GW
    Neuroscience; 2005; 130(3):667-84. PubMed ID: 15590151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid-beta immunotherapies in mice and men.
    Brendza RP; Holtzman DM
    Alzheimer Dis Assoc Disord; 2006; 20(2):118-23. PubMed ID: 16772748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropathology after active Abeta42 immunotherapy: implications for Alzheimer's disease pathogenesis.
    Boche D; Denham N; Holmes C; Nicoll JA
    Acta Neuropathol; 2010 Sep; 120(3):369-84. PubMed ID: 20632020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current progress in beta-amyloid immunotherapy.
    Schenk D; Hagen M; Seubert P
    Curr Opin Immunol; 2004 Oct; 16(5):599-606. PubMed ID: 15342006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Novel vaccine therapy for Alzheimer's disease--recent progress and our approach].
    Okura Y; Matsumoto Y
    Brain Nerve; 2008 Aug; 60(8):931-40. PubMed ID: 18717197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-mediated immunotherapy for Alzheimer's disease.
    Solomon B
    Curr Opin Investig Drugs; 2007 Jul; 8(7):519-24. PubMed ID: 17659471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons from the AN 1792 Alzheimer vaccine: lest we forget.
    Robinson SR; Bishop GM; Lee HG; Münch G
    Neurobiol Aging; 2004; 25(5):609-15. PubMed ID: 15172738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Abeta vaccine therapy for Alzheimer's disease].
    Hara H
    Rinsho Shinkeigaku; 2005 Nov; 45(11):867-9. PubMed ID: 16447748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virus and virus-like particle-based immunogens for Alzheimer's disease induce antibody responses against amyloid-beta without concomitant T cell responses.
    Chackerian B; Rangel M; Hunter Z; Peabody DS
    Vaccine; 2006 Sep; 24(37-39):6321-31. PubMed ID: 16806604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of A beta plaque clearance following passive A beta immunization.
    Morgan D
    Neurodegener Dis; 2005; 2(5):261-6. PubMed ID: 16909007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of microglial activation state following passive immunization in amyloid depositing transgenic mice.
    Morgan D
    Neurochem Int; 2006 Jul; 49(2):190-4. PubMed ID: 16740342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prophylactic and therapeutic vaccines against Alzheimer's disease].
    Zhang Z; Ma QJ
    Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):641-5. PubMed ID: 15971572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral and central biodistribution of (111)In-labeled anti-beta-amyloid autoantibodies in a transgenic mouse model of Alzheimer's disease.
    Bacher M; Depboylu C; Du Y; Noelker C; Oertel WH; Behr T; Henriksen G; Behe M; Dodel R
    Neurosci Lett; 2009 Jan; 449(3):240-5. PubMed ID: 18786612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.